AAAAAA

   
Results: 1-25 | 26-27
Results: 1-25/27
ACREMONIUM RECIFEI FUNGEMIA AFTER AUTOLOG OUS BONE-MARROW TRANSPLANTATION
Authors: MOULIAS S HAZOUARD E DELAIN M BARRABES A THERIZOLFERLY M LEGRAS A
Citation: S. Moulias et al., ACREMONIUM RECIFEI FUNGEMIA AFTER AUTOLOG OUS BONE-MARROW TRANSPLANTATION, Journal de mycologie medicale, 8(1), 1998, pp. 26-29
MEDIASTINAL LARGE-CELL LYMPHOMA WITH SCLEROSIS REFRACTORY TO CONVENTIONAL CHEMOTHERAPY CAN RESPOND AFTER DAILY ORAL CYCLOPHOSPHAMIDE
Authors: BENBOUBKER L LINASSIER C DELAIN M DEMURET A CALAIS G DEQUIN PF LAMAGNERE JP COLOMBAT P
Citation: L. Benboubker et al., MEDIASTINAL LARGE-CELL LYMPHOMA WITH SCLEROSIS REFRACTORY TO CONVENTIONAL CHEMOTHERAPY CAN RESPOND AFTER DAILY ORAL CYCLOPHOSPHAMIDE, Leukemia & lymphoma, 29(1-2), 1998, pp. 199-203
A PLACEBO-CONTROLLED STUDY OF RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR ADMINISTERED DURING AND AFTER INDUCTION TREATMENT FOR DE-NOVO ACUTE MYELOGENOUS LEUKEMIA IN ELDERLY PATIENTS
Authors: WITZ F SADOUN A PERRIN MC BERTHOU C BRIERE J CAHN JY LIOURE B WITZ B FRANCOIS S DESABLENS B PIGNON B LEPRISE PY AUDHUY B CAILLOT D CASASSUS P DELAIN M CHRISTIAN B TELLIER Z POLIN V HURTELOUP P HAROUSSEAU JL
Citation: F. Witz et al., A PLACEBO-CONTROLLED STUDY OF RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR ADMINISTERED DURING AND AFTER INDUCTION TREATMENT FOR DE-NOVO ACUTE MYELOGENOUS LEUKEMIA IN ELDERLY PATIENTS, Blood, 91(8), 1998, pp. 2722-2730
A CASE OF VENOOCCLUSIVE DISEASE COMPLICATED BY SEVERE HEMORRHAGIC CYSTITIS SUCCESSFULLY TREATED WITH RECOMBINANT PLASMINOGEN-ACTIVATOR
Authors: ARSENE O DELAIN M LINASSIER C BREMOND JL COLOMBAT P
Citation: O. Arsene et al., A CASE OF VENOOCCLUSIVE DISEASE COMPLICATED BY SEVERE HEMORRHAGIC CYSTITIS SUCCESSFULLY TREATED WITH RECOMBINANT PLASMINOGEN-ACTIVATOR, HEM CELL TH, 39(4), 1997, pp. 205-207
CEFEPIME AMIKACIN VERSUS CEFTAZIDIME/AMIKACIN AS EMPIRICAL THERAPY FOR FEBRILE EPISODES IN NEUTROPENIC PATIENTS - A COMPARATIVE-STUDY/
Authors: CORDONNIER C HERBRECHT R PICO JL GARDEMBAS M DELMER A DELAIN M MOREAU P LADEB S NALET V ROLLIN C GRES JJ
Citation: C. Cordonnier et al., CEFEPIME AMIKACIN VERSUS CEFTAZIDIME/AMIKACIN AS EMPIRICAL THERAPY FOR FEBRILE EPISODES IN NEUTROPENIC PATIENTS - A COMPARATIVE-STUDY/, Clinical infectious diseases, 24(1), 1997, pp. 41-51
LONG-TERM FOLLOW-UP OF MARROW PROGENITOR RECOVERY AFTER AUTOLOGOUS TRANSPLANTATION WITH BONE-MARROW OR PERIPHERAL-BLOOD GRAFTS
Authors: BENBOUBKER L DOMENECH J DELAIN M PICHON E BREMOND JL LINASSIER C COLOMBAT P BINET C
Citation: L. Benboubker et al., LONG-TERM FOLLOW-UP OF MARROW PROGENITOR RECOVERY AFTER AUTOLOGOUS TRANSPLANTATION WITH BONE-MARROW OR PERIPHERAL-BLOOD GRAFTS, Experimental hematology, 25(8), 1997, pp. 289-289
COMPARISON OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION AND INTENSIVE CHEMOTHERAPY AS POSTREMISSION THERAPY IN ADULT ACUTE MYELOID-LEUKEMIA
Authors: HAROUSSEAU JL CAHN JY PIGNON B WITZ F MILPIED N DELAIN M LIOURE B LAMY T DESABLENS B GUILHOT F CAILLOT D ABGRALL JF FRANCOIS S BRIERE J GUYOTAT D CASASSUS P AUDHUY B TELLIER Z HURTELOUP P HERVE P
Citation: Jl. Harousseau et al., COMPARISON OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION AND INTENSIVE CHEMOTHERAPY AS POSTREMISSION THERAPY IN ADULT ACUTE MYELOID-LEUKEMIA, Blood, 90(8), 1997, pp. 2978-2986
HEMATOPOIESIS AFTER AUTOLOGOUS STEM-CELL TRANSPLANTATION WITH MARROW OR BLOOD GRAFTS - COMPARISON OF LONG-TERM MARROW PROGENITOR RECOVERIES
Authors: BENBOUBKER L DOMENECH J DELAIN M PICHON E BREMOND JL LINASSIER C COLOMBAT P BINET C
Citation: L. Benboubker et al., HEMATOPOIESIS AFTER AUTOLOGOUS STEM-CELL TRANSPLANTATION WITH MARROW OR BLOOD GRAFTS - COMPARISON OF LONG-TERM MARROW PROGENITOR RECOVERIES, Blood, 90(10), 1997, pp. 4152-4152
THYMIDINE KINASE SERUM LEVEL IS A PREDICTIVE FACTOR FOR RESPONSE AND RELAPSE RATES AFTER FIRST LINE CHEMOTHERAPY IN PATIENTS WITH NON-HODGKINS-LYMPHOMAS
Authors: BENBOUBKER L PICHON E LINASSIER C DELAIN M VALAT C FETISSOF F TELLIER Z LAMAGNERE JP COLOMBAT P
Citation: L. Benboubker et al., THYMIDINE KINASE SERUM LEVEL IS A PREDICTIVE FACTOR FOR RESPONSE AND RELAPSE RATES AFTER FIRST LINE CHEMOTHERAPY IN PATIENTS WITH NON-HODGKINS-LYMPHOMAS, Blood, 90(10), 1997, pp. 1499-1499
AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) REPRESENTS THE BEST CONSOLIDATION THERAPY FOR ACUTE MYELOGENOUS LEUKEMIA (AML) IN 2ND COMPLETE REMISSION (CR) - A RETROSPECTIVE STUDY OF THE GOELAMS GROUP
Authors: LIOURE B WITZ F DECONNINCK E DELAIN M SOLARY E BERTHOU C AUDHUY B FRANCOIS S GUYOTAT D SADDOUN A PIGNON B HAROUSSEAU JL OBERLING F
Citation: B. Lioure et al., AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) REPRESENTS THE BEST CONSOLIDATION THERAPY FOR ACUTE MYELOGENOUS LEUKEMIA (AML) IN 2ND COMPLETE REMISSION (CR) - A RETROSPECTIVE STUDY OF THE GOELAMS GROUP, Blood, 90(10), 1997, pp. 1710-1710
G-CSF AFTER INTENSIVE CONSOLIDATION CHEMOTHERAPY IN ACUTE MYELOID-LEUKEMIA (AML)
Authors: HAROUSSEAU JL WITZ F DESABLENS B LEPRISE PY FRANCOIS S DELAIN M ABGRALL JF SOLARY E
Citation: Jl. Harousseau et al., G-CSF AFTER INTENSIVE CONSOLIDATION CHEMOTHERAPY IN ACUTE MYELOID-LEUKEMIA (AML), Blood, 90(10), 1997, pp. 2249-2249
AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) IS NOT SUPERIOR TO INTENSIVE CONSOLIDATION CHEMOTHERAPY (ICC) FOR POSTREMISSION THERAPY IN ADULT ACUTE MYELOBLASTIC-LEUKEMIA (AML) - FINAL ANALYSIS OF THE GOELAMS STUDY
Authors: CAHN JY HAROUSSEAU JL PIGNON B WITZ F DELAIN M LIOURE B LAMY T SOLARY E DESABLENS B BRIERE J CASSASUS P AUDHUY B POLIN V HURTELOUP P TELLIER Z
Citation: Jy. Cahn et al., AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) IS NOT SUPERIOR TO INTENSIVE CONSOLIDATION CHEMOTHERAPY (ICC) FOR POSTREMISSION THERAPY IN ADULT ACUTE MYELOBLASTIC-LEUKEMIA (AML) - FINAL ANALYSIS OF THE GOELAMS STUDY, Experimental hematology, 24(9), 1996, pp. 671-671
CYCLOPHOSPHAMIDE MITOXANTRONE/MELPHALAN (CMA) REGIMEN PRIOR TO AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) IN METASTATIC BREAST-CANCER/
Authors: GISSELBRECHT C EXTRA JM LOTZ JP DEVAUX Y JANVIER M PENY AM GUILLEVIN L BREMOND D DELAIN M HERBRECHT R LEPAGE E MARANINCHI D
Citation: C. Gisselbrecht et al., CYCLOPHOSPHAMIDE MITOXANTRONE/MELPHALAN (CMA) REGIMEN PRIOR TO AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) IN METASTATIC BREAST-CANCER/, Bone marrow transplantation, 18(5), 1996, pp. 857-863
GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR ACCELERATES HEMATOPOIETIC RECOVERY AFTER AUTOLOGOUS BONE-MARROW OR PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION AND HIGH-DOSE CHEMOTHERAPY FOR LYMPHOMA
Authors: COLOMBAT P DELAIN M DESBOIS I DOMENECH J BINET C TABAH I LAMAGNERE JP LINASSIER C
Citation: P. Colombat et al., GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR ACCELERATES HEMATOPOIETIC RECOVERY AFTER AUTOLOGOUS BONE-MARROW OR PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION AND HIGH-DOSE CHEMOTHERAPY FOR LYMPHOMA, Bone marrow transplantation, 18(2), 1996, pp. 293-299
INTERFERON ALPHA2B (IFN) AND CYTARABINE (ARA-C) SURVIVAL AND CYTOGENETIC RESPONSE IN CHRONIC LEUKEMIA (CML) - RESULTS OF A RANDOMIZED TRIAL
Authors: GUILHOT F CHASTANG C GUERCI A MICHALLET M HAROUSSEAU JL MALOISEL F BRIERE J BOUABDALLAH R GUYOTAT D TERTIAN G NICOLINI F ABGRALL JF NAVARRO M BLANC M BRICE P SIMON M IFRAH N ROCHANT F VILQUE JP DELAIN M GUILHOT J TANZER J
Citation: F. Guilhot et al., INTERFERON ALPHA2B (IFN) AND CYTARABINE (ARA-C) SURVIVAL AND CYTOGENETIC RESPONSE IN CHRONIC LEUKEMIA (CML) - RESULTS OF A RANDOMIZED TRIAL, Blood, 88(10), 1996, pp. 551-551
NEW ASSOCIATION OF HIGH-DOSE MITOXANTRONE (MTX), CARBOPLATIN (CBCDA) AND VP16 AS TREATMENT FOR RELAPSED OR REFRACTORY ACUTE MYELOGENOUS LEUKEMIA (AML)
Authors: LIOURE B MOREAU P WITZ F WITZ B VILQUE JP FRANCOIS S BRION A DELAIN M CASASSUS P OJEDA M CAHN JY OBERLING F HAROUSSEAU JL
Citation: B. Lioure et al., NEW ASSOCIATION OF HIGH-DOSE MITOXANTRONE (MTX), CARBOPLATIN (CBCDA) AND VP16 AS TREATMENT FOR RELAPSED OR REFRACTORY ACUTE MYELOGENOUS LEUKEMIA (AML), Blood, 88(10), 1996, pp. 848-848
S-CA125 AND LDH LEVELS AS A NEW PROGNOSTIC INDEX IN PATIENTS WITH NON-HODGKINS-LYMPHOMAS
Authors: BENBOUBKER L LINASSIER C OLLIVIER I DELAIN M VALAT C FETISSOF F LAMAGNERE JP
Citation: L. Benboubker et al., S-CA125 AND LDH LEVELS AS A NEW PROGNOSTIC INDEX IN PATIENTS WITH NON-HODGKINS-LYMPHOMAS, Blood, 88(10), 1996, pp. 883-883
RANDOMIZED STUDY OF GM-CSF POST PERIPHERAL-BLOOD STEM-CELL (PBSC) TRANSPLANT WITH PBSC COLLECTED WITH GM-CSF IN LYMPHOMAS
Authors: COLOMBAT P GARDEMBAS M DELWAUIL V MILPIED N ABGRALL JF CHASSAGNE I TABAH E DELAIN M
Citation: P. Colombat et al., RANDOMIZED STUDY OF GM-CSF POST PERIPHERAL-BLOOD STEM-CELL (PBSC) TRANSPLANT WITH PBSC COLLECTED WITH GM-CSF IN LYMPHOMAS, Blood, 88(10), 1996, pp. 1190-1190
INTENSIVE THERAPY WITH BEAM AND AUTOLOGOUS STEM-CELL TRANSPLANT IN POOR-RISK HODGKINS-DISEASE - VALUE OF RELAPSE STATUS AND PRETRANSPLANT STATUS FOR PREDICTING OUTCOME
Authors: DELAIN M MAAKHROUN A LINASSIER C BENBOUBKER L LAMAGNERE JP COLOMBAT P BRETONNEAU CHU
Citation: M. Delain et al., INTENSIVE THERAPY WITH BEAM AND AUTOLOGOUS STEM-CELL TRANSPLANT IN POOR-RISK HODGKINS-DISEASE - VALUE OF RELAPSE STATUS AND PRETRANSPLANT STATUS FOR PREDICTING OUTCOME, Experimental hematology, 23(8), 1995, pp. 754-754
LONG-TERM CULTURES TO EVALUATE ENGRAFTMENT POTENTIAL OF CD34(-BLOOD AFTER MOBILIZATION BY CHEMOTHERAPY WITH AND WITHOUT GM-CSF() CELLS FROMPERIPHERAL)
Authors: BENBOUBKER L DOMENECH J LINASSIER C DESBOIS I DELAIN M LAMAGNERE JP COLOMBAT P BINET C
Citation: L. Benboubker et al., LONG-TERM CULTURES TO EVALUATE ENGRAFTMENT POTENTIAL OF CD34(-BLOOD AFTER MOBILIZATION BY CHEMOTHERAPY WITH AND WITHOUT GM-CSF() CELLS FROMPERIPHERAL), Experimental hematology, 23(14), 1995, pp. 1568-1573
PROSPECTIVE MULTICENTRIC RANDOMIZED STUDY OF QUININE AS A POTENTIAL MDR-REVERSING AGENT FOR THE TREATMENT OF ACUTE LEUKEMIAS
Authors: SOLARY E WITZ B CAILLOT D MOREAU P DESABLENS B CAHN JY MALOISEL F SADOUN A PIGNON B GUYOTAT D CASASSUS P IFRAH N AUDHUY B BERTHOU C DELAIN M LAMY T HAROUSSEAU JL
Citation: E. Solary et al., PROSPECTIVE MULTICENTRIC RANDOMIZED STUDY OF QUININE AS A POTENTIAL MDR-REVERSING AGENT FOR THE TREATMENT OF ACUTE LEUKEMIAS, Blood, 86(10), 1995, pp. 3109-3109
PROLONGED IMPAIRMENT OF HEMATOPOIESIS AFTER HIGH-DOSE THERAPY FOLLOWED BY AUTOLOGOUS BONE-MARROW TRANSPLANTATION
Authors: DOMENECH J LINASSIER C GIHANA E DAYAN A TRUGLIO D BOUT M PETITDIDIER C DELAIN M PETIT A BREMOND JL DESBOIS I LAMAGNERE JP COLOMBAT P BINET C
Citation: J. Domenech et al., PROLONGED IMPAIRMENT OF HEMATOPOIESIS AFTER HIGH-DOSE THERAPY FOLLOWED BY AUTOLOGOUS BONE-MARROW TRANSPLANTATION, Blood, 85(11), 1995, pp. 3320-3327
VARIABILITY OF THE ALLOREACTIVE T-CELL RESPONSE TO HUMAN LEUKEMIC BLASTS
Authors: DELAIN M TIBERGHIEN P RACADOT E BILLOT M PARISET J CHABOD J CAHN JY HERVE P
Citation: M. Delain et al., VARIABILITY OF THE ALLOREACTIVE T-CELL RESPONSE TO HUMAN LEUKEMIC BLASTS, Leukemia, 8(4), 1994, pp. 642-647
VAD-PECC REGIMEN IN THE TREATMENT OF ADVANCED-STAGE MULTIPLE-MYELOMA
Authors: DELAIN M LINASSIER C PETITDIDIER C GOUPILLE P LUTHIER F COMBE M REISENLEITER M BENBOUBKER L LAMAGNERE JP COLOMBAT P
Citation: M. Delain et al., VAD-PECC REGIMEN IN THE TREATMENT OF ADVANCED-STAGE MULTIPLE-MYELOMA, Journal of clinical oncology, 12(12), 1994, pp. 2706-2713
RANDOMIZED STUDY OF GM-CSF POST PERIPHERAL-BLOOD STEM-CELL (PBSC) TRANSPLANT WITH PBSC COLLECTED WITH GM-CSF IN LYMPHOMAS
Authors: COLOMBAT P GARDEMBAS M DELWAIL V MILPIED N ABGRALL JF CHASSAGNE I TABAH E DELAIN M
Citation: P. Colombat et al., RANDOMIZED STUDY OF GM-CSF POST PERIPHERAL-BLOOD STEM-CELL (PBSC) TRANSPLANT WITH PBSC COLLECTED WITH GM-CSF IN LYMPHOMAS, Blood, 84(10), 1994, pp. 10000705-10000705
Risultati: 1-25 | 26-27